Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Transmission of a fatal clonal tumor by biting occurs due to depleted MHC diversity in a threatened carnivorous marsupial.

Siddle HV, Kreiss A, Eldridge MD, Noonan E, Clarke CJ, Pyecroft S, Woods GM, Belov K.

Proc Natl Acad Sci U S A. 2007 Oct 9;104(41):16221-6. Epub 2007 Oct 2.

2.

MHC gene copy number variation in Tasmanian devils: implications for the spread of a contagious cancer.

Siddle HV, Marzec J, Cheng Y, Jones M, Belov K.

Proc Biol Sci. 2010 Jul 7;277(1690):2001-6. doi: 10.1098/rspb.2009.2362. Epub 2010 Mar 10.

3.

Allorecognition in the Tasmanian devil (Sarcophilus harrisii), an endangered marsupial species with limited genetic diversity.

Kreiss A, Cheng Y, Kimble F, Wells B, Donovan S, Belov K, Woods GM.

PLoS One. 2011;6(7):e22402. doi: 10.1371/journal.pone.0022402. Epub 2011 Jul 21.

4.

Low MHC class II diversity in the Tasmanian devil (Sarcophilus harrisii).

Cheng Y, Sanderson C, Jones M, Belov K.

Immunogenetics. 2012 Jul;64(7):525-33. doi: 10.1007/s00251-012-0614-4. Epub 2012 Mar 31.

PMID:
22460528
5.

Lack of genetic diversity across diverse immune genes in an endangered mammal, the Tasmanian devil (Sarcophilus harrisii).

Morris KM, Wright B, Grueber CE, Hogg C, Belov K.

Mol Ecol. 2015 Aug;24(15):3860-72. doi: 10.1111/mec.13291. Epub 2015 Jul 17.

PMID:
26119928
6.

Characterization of major histocompatibility complex class I and class II genes from the Tasmanian devil (Sarcophilus harrisii).

Siddle HV, Sanderson C, Belov K.

Immunogenetics. 2007 Sep;59(9):753-60. Epub 2007 Aug 3.

PMID:
17673996
7.

Antigen-presenting genes and genomic copy number variations in the Tasmanian devil MHC.

Cheng Y, Stuart A, Morris K, Taylor R, Siddle H, Deakin J, Jones M, Amemiya CT, Belov K.

BMC Genomics. 2012 Mar 12;13:87. doi: 10.1186/1471-2164-13-87.

8.

Characterisation of non-classical MHC class I genes in the Tasmanian devil (Sarcophilus harrisii).

Cheng Y, Belov K.

Immunogenetics. 2014 Dec;66(12):727-35. doi: 10.1007/s00251-014-0804-3. Epub 2014 Sep 30.

PMID:
25267059
9.

The role of the Major Histocompatibility Complex in the spread of contagious cancers.

Belov K.

Mamm Genome. 2011 Feb;22(1-2):83-90. doi: 10.1007/s00335-010-9294-2. Epub 2010 Oct 21. Review.

PMID:
20963591
10.

The role of MHC genes in contagious cancer: the story of Tasmanian devils.

Caldwell A, Siddle HV.

Immunogenetics. 2017 Aug;69(8-9):537-545. doi: 10.1007/s00251-017-0991-9. Epub 2017 Jul 11. Review.

11.

Characterization of antibody V segment diversity in the Tasmanian devil (Sarcophilus harrisii).

Ujvari B, Belov K.

Vet Immunol Immunopathol. 2015 Oct 15;167(3-4):156-65. doi: 10.1016/j.vetimm.2015.08.001. Epub 2015 Aug 14.

PMID:
26300316
12.

Genomic insights into a contagious cancer in Tasmanian devils.

Grueber CE, Peel E, Gooley R, Belov K.

Trends Genet. 2015 Sep;31(9):528-35. doi: 10.1016/j.tig.2015.05.001. Epub 2015 May 29. Review.

PMID:
26027792
13.

New insights into the role of MHC diversity in devil facial tumour disease.

Lane A, Cheng Y, Wright B, Hamede R, Levan L, Jones M, Ujvari B, Belov K.

PLoS One. 2012;7(6):e36955. doi: 10.1371/journal.pone.0036955. Epub 2012 Jun 6.

14.

Genetic diversity and population structure of the endangered marsupial Sarcophilus harrisii (Tasmanian devil).

Miller W, Hayes VM, Ratan A, Petersen DC, Wittekindt NE, Miller J, Walenz B, Knight J, Qi J, Zhao F, Wang Q, Bedoya-Reina OC, Katiyar N, Tomsho LP, Kasson LM, Hardie RA, Woodbridge P, Tindall EA, Bertelsen MF, Dixon D, Pyecroft S, Helgen KM, Lesk AM, Pringle TH, Patterson N, Zhang Y, Kreiss A, Woods GM, Jones ME, Schuster SC.

Proc Natl Acad Sci U S A. 2011 Jul 26;108(30):12348-53. doi: 10.1073/pnas.1102838108. Epub 2011 Jun 27. Erratum in: Proc Natl Acad Sci U S A. 2012 Nov 6;109(45):18625.

15.

Development of a SNP-based assay for measuring genetic diversity in the Tasmanian devil insurance population.

Wright B, Morris K, Grueber CE, Willet CE, Gooley R, Hogg CJ, O'Meally D, Hamede R, Jones M, Wade C, Belov K.

BMC Genomics. 2015 Oct 14;16:791. doi: 10.1186/s12864-015-2020-4.

16.

Low major histocompatibility complex diversity in the Tasmanian devil predates European settlement and may explain susceptibility to disease epidemics.

Morris K, Austin JJ, Belov K.

Biol Lett. 2012 Dec 5;9(1):20120900. doi: 10.1098/rsbl.2012.0900. Print 2013 Feb 23.

17.

Demonstration of immune responses against devil facial tumour disease in wild Tasmanian devils.

Pye R, Hamede R, Siddle HV, Caldwell A, Knowles GW, Swift K, Kreiss A, Jones ME, Lyons AB, Woods GM.

Biol Lett. 2016 Oct;12(10). pii: 20160553. doi: 10.1098/rsbl.2016.0553.

18.

Reversible epigenetic down-regulation of MHC molecules by devil facial tumour disease illustrates immune escape by a contagious cancer.

Siddle HV, Kreiss A, Tovar C, Yuen CK, Cheng Y, Belov K, Swift K, Pearse AM, Hamede R, Jones ME, Skjødt K, Woods GM, Kaufman J.

Proc Natl Acad Sci U S A. 2013 Mar 26;110(13):5103-8. doi: 10.1073/pnas.1219920110. Epub 2013 Mar 11.

19.

Devil Facial Tumor Disease.

Pye RJ, Woods GM, Kreiss A.

Vet Pathol. 2016 Jul;53(4):726-36. doi: 10.1177/0300985815616444. Epub 2015 Dec 13. Review.

PMID:
26657222
20.

[Is cancer a transmittable disease?].

Meléndez-Zajgla J, Maldonado V.

Gac Med Mex. 2007 Jul-Aug;143(4):353-4. Spanish.

PMID:
17969847

Supplemental Content

Support Center